Table 2A.
Known mutations identified in 81 IPN genes by next-generation sequencing
Patient | Disease classification | Inheritance | Gene | Haplotype | cDNA change | Amino acid change | ACMG classification | Report |
2 | CMT1 | AR | SH3TC2 | comp het | c.[211C>T];[2860C>T] | p.[Gln71*];[Arg954*] | P/P | Senderek et al 25 |
3 | CMT1 | SPO | GJB1 | het | c.223C>T | p.Arg75Trp | P | Silander et al 26 |
6 | HMN | AD | TRPV4 | het | c.806G>A | p.Arg269His | P | Landouré et al 27 |
8 | CMT2 | AR | MFN2 GDAP1 | het | c.707C>T c.473C>T | p.Thr236Met p.Thr158Ile | PP PP | Kijima et al 28 |
9 | CMT1 | AD | DNM2 | het | c.1597G>A | p.Gly533Ser | PP | Fabrizi et al 29 |
10 | CMT1 | AD | NEFL | het | c.1319 C>T | p.Pro440Leu | PP | Benedetti et al 30 |
11 | CMT2 | AR | IGHMBP2 | comp het | c.[2368C>T];[2911_2912delAG] | p.[Arg790*];[Arg971Glufs4*] | P/P | Maystadt et al 31 |
15 | CMT1 | AD | LITAF | het | c.334G>A | p.Gly112Ser | P | Street et al 32 |
17 | CMT1 | AR | GDAP1 | hoz | c.786_786delG | p.Phe263Leufs*22 | P | Nelis et al 33 |
18 | CMT1 | AD | AARS | het | c.986G>A | p.Arg329His | P | Latour et al 34 |
20 | CMT1 | AR | FIG4 | comp het | c.[122T>C];[830_837delGTAAATTT] | p.[Ile41Thr];[Lys278Trpfs*6] | PP/P | Chow et al 35 |
23 | CMT2 | AR | GDAP1 DCTN1 | het | c.358C>T c.2384G>A | p.Arg120Trp p.Arg795His | P PP | Pedrola et al,36 Sivera et al 37 |
28 | CMT1 | AD | LITAF DCTN1 | het | c.334G>A c.875G>A | p.Gly112Ser p.Arg292His | PP VUS | Street et al 32 |
31 | CMT2 | AD | NEFL | het | c.803T>G | p.Leu268Arg | PP | Fabrizi et al 38 |
32 | CMT1 | SPO | NEFL | het | c.293A>G | p.Asn98Ser | PP | Yoshihara et al 39 |
41 | CMT1 | AR | SH3TC2 | hoz | c.3325 C>T | p.Arg1109* | P | Gooding et al 40 |
42 | CMT2 | AD | MFN2 | het | c.311G>T | p.Arg104Leu | P | Sitarz et al 41 |
43 | CMT2 | AD | BAG3 | het | c.343C>T | p.Pro115Ser | PP | Villard et al,42 Selcen et al 43 |
47 | CMT1 | AR | HK1 | comp het | c.(1–22124G>C];[c.1–20809 G>A] | PP/PP | Hantke et al 44 | |
51 | CMT2 | AD | HSPB1 | het | c.523C>T | p.Gln175* | P | Rossor et al 45 |
53 | CMT2 | AD | NEFL | het | c.998T>C | p.Leu333Pro | PP | Choi et al 46 |
54 | CMT2 | AR | GAN | comp het | c.[1429C>T];[1724T>C] | p.[Arg477*];[Ile575Thr] | P/VUS | Bomont et al 47 |
56 | HSAN | AD | SPTLC2 MYH14 | het | c.547 C>T c.71C>G | p.Arg183Trp p.Ala24Gly | PP VUS | Suriyanarayanan et al 48 |
60 | CMT2 | AD | AARS | het | c.986G>A | p.Arg329His | P | Latour et al 34 |
AD, autosomal dominant; AR, autosomal recessive; CMT1, Charcot-Marie-Tooth disease type 1; CMT2, Charcot-Marie-Tooth disease type 2; comp het, compound heterozygous; het, heterozygous; HMN, hereditary motor neuropathy; hoz, homozygous; HSAN, hereditary sensory and autonomic neuropathy; IPN, inherited peripheral neuropathy; P, pathogenic; PP, probably pathogenic; SPO, sporadic; VUS, variant of unknown significance.